Rather than serving as a first-line treatment, it is typically considered an adjunctive therapy that may complement more established approaches, such as physical therapy, exercise modification, and other evidence-based interventions
Patients lose weight but often lose muscle, energy, and metabolic resilience along the way
[7] Although SPCD is an autosomal recessive condition, heterozygotes have been shown to be at an increased risk for developing benign cardiomyopathy compared to wild type individuals
Side-effect management guided by health care providers with expertise in managing patients with obesity is also key
Stable Gastric Pentadecapeptide BPC 157 and Bupivacaine
Importantly, the peptide does this without inducing tumor growth, suggesting it promotes healthy longevity